The global epidemic trend analysis of influenza type B drug resistance sites from 2006 to 2018

Conclusions: We found the D197N mutation in Clust04 of the 2018 influenza B virus, with a large number of N198, S295, K373, and K375 mutations in the helper sites around N197, N294, and R374 from 2006 to 2018. NA inhibitors are currently the only kind of specific antiviral agent for the influenza B virus, although these mutations cause mild NAIs resistance.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Authors: Source Type: research